Porton Biopharma
Porton Biopharma Limited (PBL) is a UK-based company experienced in developing, manufacturing and bringing life-saving biopharmaceutical therapeutics and vaccines to market.
Trending Articles
-
You need to be a subscriber to read this article.
Click here to find out more.
Related Content
Ingredients
Recombinant cultures for superior enzyme output
A non-GMP enzyme manufacturing process at Porton Biopharma has been converted from native production to recombinant using bioinformatics and next-gen sequencing. David Gervais, Head of Product and Fermentation Development, explains the method
Research & Development
UK biotech to manufacture novel IBD medicines using gut bacteria spores
Chain Biotech, Porton Biopharma and Scitech have obtained grant funding from Innovate UK to investigate the manufacture of a new class of medicines, targeting a range of clinical conditions such as ulcerative colitis and Crohn’s disease through interaction with the human microbiome